Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,080
Closed -$380K 260
2026
Q1
$380K Sell
1,080
-465
-30% -$166K 0.19% 166
2025
Q4
$506K Buy
+1,545
New +$490K 0.18% 161
2024
Q2
Sell
-3,080
Closed -$876K 229
2024
Q1
$876K Buy
+3,080
New +$901K 0.5% 71
2023
Q4
Sell
-3,165
Closed -$851K 203
2023
Q3
$851K Buy
3,165
+463
+17% +$116K 0.54% 63
2023
Q2
$600K Buy
+2,702
New +$627K 0.54% 70

Other funds holding AMGN

iSAM Funds (UK)'s AMGN Position: Q2 2026 in Review

iSAM Funds (UK) sold out of Amgen (AMGN) in Q2 2026, closing a stake of 1,080 shares — an estimated $380K sold.

iSAM Funds (UK) first reported a position in AMGN in Q2 2023 and held it in 5 quarters. The position peaked at $876K in Q1 2024. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • iSAM Funds (UK) reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • iSAM Funds (UK) sold 1,080 Amgen shares in Q2 2026, an estimated $380K.
  • iSAM Funds (UK) first reported a position in Amgen in Q2 2023 and held it in 5 quarters.
  • iSAM Funds (UK)'s Amgen position peaked at $876K in Q1 2024.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.